28090049 Visualization
Back to Main Page
A
46
Age
-
year
Age
-
old
Age
woman
Sex
with a history of
Graves'
History
disease
History
(GD)
History
was
transferred
Clinical_event
to our
emergency
Nonbiological_location
department
Nonbiological_location
on suspicion of
DKA
Disease_disorder
.She had noticed
polydipsia
Sign_symptom
,
polyuria
Sign_symptom
, and
fatigue
Sign_symptom
approximately
four
Duration
months
Duration
prior
Duration
to
Duration
admission
Duration
.She had also been suffering from a
1
Duration
-
month
Duration
complaint of
appetite
Sign_symptom
loss
Sign_symptom
, approximately
7
Lab_value
kg
Lab_value
weight
Sign_symptom
loss
Sign_symptom
,
fatigue
Sign_symptom
,
nausea
Sign_symptom
, and
sweating
Sign_symptom
.Her medical history included
GD
Disease_disorder
,
diagnosed
Date
at
Date
42
Date
years
Date
of
Date
age
Date
and
History
managed
History
with
History
methimazole
History
.However, she had
poor
Lab_value
compliance
Lab_value
with
anti
Medication
-
thyroid
Medication
drugs
Medication
.She
denied
History
a
History
family
History
history
History
of
History
thyroid
History
diseases
History
or
History
diabetes
History
.
Three
Date
days
Date
before
Date
admission
Date
, she was also
diagnosed
Clinical_event
with
influenza
Disease_disorder
A
Disease_disorder
at a
nearby
Nonbiological_location
hospital
Nonbiological_location
, and
oseltamivir
Medication
phosphate
Medication
was prescribed.At the
emergency
Nonbiological_location
department
Nonbiological_location
, she
presented
Clinical_event
with
drowsiness
Sign_symptom
and a
body
Diagnostic_procedure
temperature
Diagnostic_procedure
of
37.0℃
Lab_value
,
blood
Diagnostic_procedure
pressure
Diagnostic_procedure
of
90/60
Lab_value
mmHg
Lab_value
,
heart
Diagnostic_procedure
rate
Diagnostic_procedure
of
200
Lab_value
bpm
Lab_value
,
respiratory
Diagnostic_procedure
rate
Diagnostic_procedure
of
32
Lab_value
breaths/min
Lab_value
,
oxygen
Diagnostic_procedure
saturation
Diagnostic_procedure
of
99%
Lab_value
in
5
Lab_value
L
Lab_value
nasal
Lab_value
air
Lab_value
, and a
Glasgow
Diagnostic_procedure
coma
Diagnostic_procedure
scale
Diagnostic_procedure
(
GCS
Diagnostic_procedure
) score of
14
Lab_value
.Her
clinical
Diagnostic_procedure
examination
Diagnostic_procedure
revealed a
diffuse
Detailed_description
goiter
Sign_symptom
with
bilateral
Detailed_description
exophthalmoses
Detailed_description
.Her
lungs
Biological_structure
were
clear
Lab_value
when
auscultated
Diagnostic_procedure
.Her
abdomen
Biological_structure
was
soft
Lab_value
and non-
tender
Sign_symptom
.Her
skin
Biological_structure
was
warm
Lab_value
and
wet
Lab_value
.She had no
lower
Biological_structure
extremity
Biological_structure
edema
Sign_symptom
.The
electrocardiogram
Diagnostic_procedure
showed
marked
Detailed_description
tachycardia
Sign_symptom
with
atrial
Disease_disorder
fibrillation
Disease_disorder
, and a
chest
Biological_structure
radiograph
Diagnostic_procedure
was
normal
Lab_value
.The
laboratory
Diagnostic_procedure
data
Diagnostic_procedure
are shown in Table 1.Her initial
laboratory
Diagnostic_procedure
data
Diagnostic_procedure
demonstrated marked
metabolic
Sign_symptom
acidosis
Sign_symptom
, an
increased
Lab_value
plasma
Diagnostic_procedure
glucose
Diagnostic_procedure
level of
472
Lab_value
mg/dL
Lab_value
, an
increased
Lab_value
HbA1c
Diagnostic_procedure
level of
13.7%
Lab_value
, an
increased
Lab_value
free
Diagnostic_procedure
triiodothyronine
Diagnostic_procedure
level of
6.440
Lab_value
pg/mL
Lab_value
, and a
free
Diagnostic_procedure
thyroxine
Diagnostic_procedure
level of
2.830
Lab_value
ng/dL
Lab_value
, with a
suppressed
Diagnostic_procedure
thyrotropin
Diagnostic_procedure
(TSH) level of
0.005
Lab_value
μIU/mL.She scored
55
Lab_value
on the
diagnostic
Diagnostic_procedure
criteria
Diagnostic_procedure
of
Diagnostic_procedure
Burch
Diagnostic_procedure
&
Diagnostic_procedure
Wartofsky
Diagnostic_procedure
for
Diagnostic_procedure
thyroid
Diagnostic_procedure
storm
Diagnostic_procedure
, and the
diagnostic
Diagnostic_procedure
criteria
Diagnostic_procedure
of
Diagnostic_procedure
the
Diagnostic_procedure
Japan
Diagnostic_procedure
Thyroid
Diagnostic_procedure
Association
Diagnostic_procedure
for
Diagnostic_procedure
thyroid
Diagnostic_procedure
storm
Diagnostic_procedure
were also
satisfied
Lab_value
, since she had
thyrotoxicosis
Disease_disorder
,
symptoms
Sign_symptom
involving
Sign_symptom
the
Sign_symptom
central
Sign_symptom
nervous
Sign_symptom
system
Sign_symptom
,
tachycardia
Sign_symptom
, and
gastrointestinal
Sign_symptom
symptoms
Sign_symptom
(4).Accordingly, she was
diagnosed
Clinical_event
with
DKA
Disease_disorder
and
thyroid
Disease_disorder
storm
Disease_disorder
and
admitted
Clinical_event
to the
medical
Nonbiological_location
intensive
Nonbiological_location
care
Nonbiological_location
unit
Nonbiological_location
for further
monitoring
Diagnostic_procedure
and
treatment
Therapeutic_procedure
.The clinical course is shown in Figure.She was treated with an
intravenous
Administration
insulin
Medication
drip
Administration
and
aggressive
Detailed_description
intravenous
Administration
fluid
Therapeutic_procedure
therapy
Therapeutic_procedure
.The
thyroid
Disease_disorder
storm
Disease_disorder
with
GD
Disease_disorder
was treated with
intravenous
Administration
hydrocortisone
Medication
100
Dosage
mg
Dosage
every
Dosage
8
Dosage
hours
Dosage
,
oral
Administration
potassium
Medication
iodine
Medication
50
Dosage
mg
Dosage
every
Dosage
6
Dosage
hours
Dosage
, and
oral
Administration
methimazole
Medication
20
Dosage
mg
Dosage
every
Dosage
6
Dosage
hours
Dosage
.Since she had a history of
asthma
History
,
landiolol
Medication
hydrochloride
Medication
, a short-acting beta-adrenoceptor blocker, was used at
4
Dosage
-
12
Dosage
μg/kg/min
Dosage
to control her heart rate.By
Day
Date
3
Date
, her
tachycardia
Sign_symptom
had resolved, and
landiolol
Medication
hydrochloride
Medication
was discontinued.On
Day
Date
6
Date
, the
white
Diagnostic_procedure
blood
Diagnostic_procedure
cell
Diagnostic_procedure
count
Diagnostic_procedure
had decreased to
2,800
Lab_value
cells/mm3
Lab_value
[
neutrophils,
Lab_value
44.2%
Lab_value
(1,238
Lab_value
cells/mm3)
Lab_value
].
Methimazole
Medication
was discontinued because
methimazole
Detailed_description
-
induced
Detailed_description
neutropenia
Sign_symptom
was suspected.The patient was
referred
Clinical_event
to an
endocrine
Nonbiological_location
surgeon
Nonbiological_location
, and
thyroidectomy
Therapeutic_procedure
was performed on
Day
Date
32
Date
.She was
discharged
Clinical_event
from the
hospital
Nonbiological_location
on
Day
Date
37
Date
and maintained on
multiple
Dosage
daily
Dosage
insulin
Medication
infusion
Administration
and
levothyroxine
Medication
sodium
Medication
hydrate
Medication
.Further
immunological
Diagnostic_procedure
investigation
Diagnostic_procedure
revealed
elevated
Lab_value
levels
Lab_value
of
anti
Diagnostic_procedure
-
glutamic
Diagnostic_procedure
acid
Diagnostic_procedure
decarboxylase
Diagnostic_procedure
(GAD)
Diagnostic_procedure
antibody
Diagnostic_procedure
,
anti
Diagnostic_procedure
-
insulinoma
Diagnostic_procedure
antigen
Diagnostic_procedure
2
Diagnostic_procedure
(IA-2)
antibody
Diagnostic_procedure
, and
insulin
Diagnostic_procedure
autoantibody
Diagnostic_procedure
, consistent with T1D.The
intravenous
Diagnostic_procedure
glucagon
Diagnostic_procedure
stimulation
Diagnostic_procedure
test
Diagnostic_procedure
was performed with
blood
Biological_structure
samples
Biological_structure
for
Detailed_description
glucose
Detailed_description
and
Detailed_description
C
Detailed_description
-
peptide
Detailed_description
taken
Detailed_description
at
Detailed_description
baseline
Detailed_description
and
Detailed_description
6
Detailed_description
minutes
Detailed_description
.Her
plasma
Diagnostic_procedure
glucose
Diagnostic_procedure
levels were
139
Lab_value
and
152
Lab_value
mg/dL
Lab_value
at
baseline
Detailed_description
and
6
Detailed_description
minutes
Detailed_description
, respectively.The corresponding
serum
Diagnostic_procedure
C
Diagnostic_procedure
-
peptide
Diagnostic_procedure
levels were
0.8
Lab_value
and
1.3
Lab_value
ng/mL
Lab_value
at
baseline
Detailed_description
and
6
Detailed_description
minutes
Detailed_description
, respectively.